$ZTS
Zoetis Inc.

2017 Q2 Form 10-Q Financial Statement

#000155528017000127 Filed on May 04, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $1.231B $1.162B
YoY Change 5.94% -1.11%
Cost Of Revenue $443.0M $389.0M
YoY Change 13.88% -8.9%
Gross Profit $788.0M $773.0M
YoY Change 1.94% 3.34%
Gross Profit Margin 64.01% 66.52%
Selling, General & Admin $309.0M $315.0M
YoY Change -1.9% -16.89%
% of Gross Profit 39.21% 40.75%
Research & Development $90.00M $90.00M
YoY Change 0.0% 7.14%
% of Gross Profit 11.42% 11.64%
Depreciation & Amortization $62.00M $57.00M
YoY Change 8.77% 14.0%
% of Gross Profit 7.87% 7.37%
Operating Expenses $399.0M $405.0M
YoY Change -1.48% -12.53%
Operating Profit $389.0M $368.0M
YoY Change 5.71% 29.12%
Interest Expense $41.00M $43.00M
YoY Change -4.65% 48.28%
% of Operating Profit 10.54% 11.68%
Other Income/Expense, Net $10.00M $30.00M
YoY Change -66.67% -1600.0%
Pretax Income $337.0M $332.0M
YoY Change 1.51% -1329.63%
Income Tax $98.00M $128.0M
% Of Pretax Income 29.08% 38.55%
Net Earnings $238.0M $204.0M
YoY Change 16.67% -651.35%
Net Earnings / Revenue 19.33% 17.56%
Basic Earnings Per Share $0.48 $0.41
Diluted Earnings Per Share $0.48 $0.41
COMMON SHARES
Basic Shares Outstanding 492.4M shares 497.4M shares
Diluted Shares Outstanding 495.3M shares 499.5M shares

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $629.0M $675.0M
YoY Change -6.81% 24.08%
Cash & Equivalents $629.0M $675.0M
Short-Term Investments
Other Short-Term Assets $265.0M $236.0M
YoY Change 12.29% 0.43%
Inventory $1.535B $1.461B
Prepaid Expenses
Receivables $954.0M $908.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.383B $3.307B
YoY Change 2.3% -0.27%
LONG-TERM ASSETS
Property, Plant & Equipment $1.368B $1.317B
YoY Change 3.87% 1.7%
Goodwill $1.497B $1.459B
YoY Change 2.6% 25.02%
Intangibles $1.232B $1.210B
YoY Change 1.82% 73.6%
Long-Term Investments
YoY Change
Other Assets $72.00M $48.00M
YoY Change 50.0% -17.24%
Total Long-Term Assets $4.266B $4.146B
YoY Change 2.89% 26.33%
TOTAL ASSETS
Total Short-Term Assets $3.383B $3.307B
Total Long-Term Assets $4.266B $4.146B
Total Assets $7.649B $7.453B
YoY Change 2.63% 12.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $231.0M $210.0M
YoY Change 10.0% -24.46%
Accrued Expenses $566.0M $718.0M
YoY Change -21.17% -9.34%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $750.0M $0.00
YoY Change -100.0%
Total Short-Term Liabilities $1.730B $1.163B
YoY Change 48.75% -26.02%
LONG-TERM LIABILITIES
Long-Term Debt $3.718B $4.464B
YoY Change -16.71% 37.65%
Other Long-Term Liabilities $215.0M $246.0M
YoY Change -12.6% -14.58%
Total Long-Term Liabilities $3.933B $4.710B
YoY Change -16.5% 33.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.730B $1.163B
Total Long-Term Liabilities $3.933B $4.710B
Total Liabilities $6.014B $6.266B
YoY Change -4.02% 16.12%
SHAREHOLDERS EQUITY
Retained Earnings $1.651B $1.016B
YoY Change 62.5% 27.8%
Common Stock $5.000M $5.000M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $510.0M $245.0M
YoY Change 108.16% 145.0%
Treasury Stock Shares 10.56M shares 5.475M shares
Shareholders Equity $1.609B $1.165B
YoY Change
Total Liabilities & Shareholders Equity $7.649B $7.453B
YoY Change 2.63% 12.96%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income $238.0M $204.0M
YoY Change 16.67% -651.35%
Depreciation, Depletion And Amortization $62.00M $57.00M
YoY Change 8.77% 14.0%
Cash From Operating Activities $119.0M $51.00M
YoY Change 133.33% -58.2%
INVESTING ACTIVITIES
Capital Expenditures $42.00M $45.00M
YoY Change -6.67% -116.36%
Acquisitions $3.000M $12.00M
YoY Change -75.0%
Other Investing Activities $3.000M $0.00
YoY Change -100.0%
Cash From Investing Activities -$48.00M $18.00M
YoY Change -366.67% -140.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $125.0M $76.00M
YoY Change 64.47%
Debt Paid & Issued, Net $0.00 $400.0M
YoY Change -100.0%
Cash From Financing Activities -$176.0M -$543.0M
YoY Change -67.59% 496.7%
NET CHANGE
Cash From Operating Activities $119.0M $51.00M
Cash From Investing Activities -$48.00M $18.00M
Cash From Financing Activities -$176.0M -$543.0M
Net Change In Cash -$105.0M -$474.0M
YoY Change -77.85% 3546.15%
FREE CASH FLOW
Cash From Operating Activities $119.0M $51.00M
Capital Expenditures $42.00M $45.00M
Free Cash Flow $77.00M $6.000M
YoY Change 1183.33% -98.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 dei Amendment Flag
AmendmentFlag
false
CY2017Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q2 dei Document Period End Date
DocumentPeriodEndDate
2017-04-02
CY2017Q2 dei Document Type
DocumentType
10-Q
CY2017Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001555280
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
490796861 shares
CY2017Q2 dei Entity Registrant Name
EntityRegistrantName
Zoetis Inc.
CY2017Q2 dei Trading Symbol
TradingSymbol
ZTS
CY2016Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
73000000 USD
CY2017Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
79000000 USD
CY2016Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13000000 USD
CY2017Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14000000 USD
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9000000 USD
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11000000 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
30000000 USD
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
265000000 USD
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
231000000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
913000000 USD
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
32000000 USD
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24000000 USD
CY2017Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
25000000 USD
CY2016Q4 us-gaap Assets
Assets
7649000000 USD
CY2017Q2 us-gaap Assets
Assets
7649000000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
3390000000 USD
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
954000000 USD
CY2017Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1358000000 USD
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1435000000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-598000000 USD
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-552000000 USD
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1024000000 USD
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1015000000 USD
CY2017Q2 us-gaap Assets Current
AssetsCurrent
3383000000 USD
CY2016Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
9000000 USD
CY2017Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4000000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1154000000 USD
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
675000000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
727000000 USD
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
629000000 USD
CY2016Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-479000000 USD
CY2017Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-98000000 USD
CY2016Q4 us-gaap Commercial Paper
CommercialPaper
0 USD
CY2017Q2 us-gaap Commercial Paper
CommercialPaper
0 USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.095
CY2017Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.105
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000 shares
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
501810000 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
501890000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
501891243 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
501890000 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
501890000 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
501891243 shares
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
496416809 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
492855297 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
491328479 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
5000000 USD
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
5000000 USD
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
208000000 USD
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
284000000 USD
CY2016Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1000000 USD
CY2017Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1000000 USD
CY2016Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
207000000 USD
CY2017Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
285000000 USD
CY2016Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
389000000 USD
CY2017Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
443000000 USD
CY2016Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
4500000000 USD
CY2017Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
4500000000 USD
CY2016Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-32000000 USD
CY2017Q2 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-32000000 USD
CY2016Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-25000000 USD
CY2017Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
24000000 USD
CY2016Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
96000000 USD
CY2017Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
97000000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
148000000 USD
CY2017Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
175000000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
244000000 USD
CY2017Q2 us-gaap Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
272000000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
244000000 USD
CY2017Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
272000000 USD
CY2016Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
1000000 USD
CY2017Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
1000000 USD
CY2016Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
1000000 USD
CY2017Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
1000000 USD
CY2016Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
2000000 USD
CY2017Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
3000000 USD
CY2016Q2 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
0 USD
CY2017Q2 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
-1000000 USD
CY2016Q2 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
2000000 USD
CY2017Q2 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
2000000 USD
CY2016Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
57000000 USD
CY2017Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
62000000 USD
CY2016Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
21000000 USD
CY2017Q2 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
7000000 USD
CY2016Q2 us-gaap Dividends Common Stock
DividendsCommonStock
49000000 USD
CY2017Q2 us-gaap Dividends Common Stock
DividendsCommonStock
52000000 USD
CY2016Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
52000000 USD
CY2017Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
52000000 USD
CY2016Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
49000000 USD
CY2017Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
52000000 USD
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.41
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.48
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2016Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-5000000 USD
CY2017Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
7000000 USD
CY2016Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.386
CY2017Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.291
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
224000000 USD
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
183000000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
648000000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
674000000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1561000000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1661000000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
913000000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
987000000 USD
CY2016Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-9000000 USD
CY2017Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2000000 USD
CY2016Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
33000000 USD
CY2017Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2016Q2 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
33000000 USD
CY2017Q2 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
0 USD
CY2016Q4 us-gaap Goodwill
Goodwill
1481000000 USD
CY2017Q2 us-gaap Goodwill
Goodwill
1497000000 USD
CY2017Q2 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
10000000 USD
CY2016Q4 us-gaap Goodwill Gross
GoodwillGross
2017000000 USD
CY2017Q2 us-gaap Goodwill Gross
GoodwillGross
2033000000 USD
CY2016Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
536000000 USD
CY2017Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
536000000 USD
CY2017Q2 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
6000000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
332000000 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
337000000 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
128000000 USD
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
98000000 USD
CY2016Q2 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
10000000 USD
CY2017Q2 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
3000000 USD
CY2016Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
49000000 USD
CY2017Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
37000000 USD
CY2016Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-84000000 USD
CY2017Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-37000000 USD
CY2016Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-21000000 USD
CY2017Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
22000000 USD
CY2016Q2 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
114000000 USD
CY2017Q2 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
34000000 USD
CY2016Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3000000 USD
CY2017Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
52000000 USD
CY2016Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
36000000 USD
CY2017Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
13000000 USD
CY2016Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-193000000 USD
CY2017Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-147000000 USD
CY2016Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
315000000 USD
CY2017Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
245000000 USD
CY2016Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1876000000 USD
CY2017Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1906000000 USD
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1228000000 USD
CY2017Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1232000000 USD
CY2017Q2 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1000000 USD
CY2016Q2 us-gaap Interest Expense
InterestExpense
43000000 USD
CY2017Q2 us-gaap Interest Expense
InterestExpense
41000000 USD
CY2016Q2 us-gaap Interest Paid Net
InterestPaidNet
58000000 USD
CY2017Q2 us-gaap Interest Paid Net
InterestPaidNet
56000000 USD
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
799000000 USD
CY2017Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
800000000 USD
CY2016Q4 us-gaap Inventory Net
InventoryNet
1502000000 USD
CY2017Q2 us-gaap Inventory Net
InventoryNet
1535000000 USD
CY2016Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
204000000 USD
CY2017Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
204000000 USD
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
499000000 USD
CY2017Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
531000000 USD
CY2016Q2 us-gaap Inventory Write Down
InventoryWriteDown
16000000 USD
CY2017Q2 us-gaap Inventory Write Down
InventoryWriteDown
16000000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
6150000000 USD
CY2017Q2 us-gaap Liabilities
Liabilities
6014000000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7649000000 USD
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7649000000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1117000000 USD
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1730000000 USD
CY2016Q4 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2017Q2 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2017Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
75000000 USD
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2017Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
750000000 USD
CY2017Q2 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
3250000000 USD
CY2017Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
0 USD
CY2017Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
500000000 USD
CY2017Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 USD
CY2017Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
750000000 USD
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4468000000 USD
CY2017Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3718000000 USD
CY2016Q4 us-gaap Minority Interest
MinorityInterest
12000000 USD
CY2017Q2 us-gaap Minority Interest
MinorityInterest
26000000 USD
CY2016Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-543000000 USD
CY2017Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-176000000 USD
CY2016Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
18000000 USD
CY2017Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-48000000 USD
CY2016Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
51000000 USD
CY2017Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
119000000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
204000000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
238000000 USD
CY2016Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2017Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
30000000 USD
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10000000 USD
CY2017Q2 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
45 country
CY2017Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2016Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
464000000 USD
CY2017Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
383000000 USD
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
248000000 USD
CY2017Q2 us-gaap Other Assets Current
OtherAssetsCurrent
265000000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
73000000 USD
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
72000000 USD
CY2016Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
1000000 USD
CY2017Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
2000000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2000000 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
44000000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3000000 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
46000000 USD
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
41000000 USD
CY2017Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
31000000 USD
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
248000000 USD
CY2017Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
215000000 USD
CY2016Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
0 USD
CY2017Q2 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
750000000 USD
CY2016Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1000000 USD
CY2017Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-4000000 USD
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000000 USD
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5000000 USD
CY2016Q2 us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
27000000 USD
CY2017Q2 us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
2000000 USD
CY2016Q2 us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
22000000 USD
CY2017Q2 us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
5000000 USD
CY2016Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2017Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
3000000 USD
CY2016Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
76000000 USD
CY2017Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
125000000 USD
CY2016Q2 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
47000000 USD
CY2017Q2 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
52000000 USD
CY2016Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
12000000 USD
CY2017Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3000000 USD
CY2016Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
45000000 USD
CY2017Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
42000000 USD
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000000 shares
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000000 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2017Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2016Q2 us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
3000000 USD
CY2017Q2 us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
6000000 USD
CY2016Q2 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-1000000 USD
CY2017Q2 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
0 USD
CY2016Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
75000000 USD
CY2017Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2016Q2 us-gaap Professional Fees
ProfessionalFees
5000000 USD
CY2016Q2 us-gaap Profit Loss
ProfitLoss
204000000 USD
CY2017Q2 us-gaap Profit Loss
ProfitLoss
239000000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1381000000 USD
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1368000000 USD
CY2016Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
400000000 USD
CY2017Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2016Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
90000000 USD
CY2017Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
90000000 USD
CY2017Q2 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
2200
CY2017Q2 us-gaap Restructuring Charges
RestructuringCharges
-1000000 USD
CY2016Q4 us-gaap Restructuring Reserve
RestructuringReserve
90000000 USD
CY2017Q2 us-gaap Restructuring Reserve
RestructuringReserve
67000000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1477000000 USD
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1651000000 USD
CY2016Q2 us-gaap Royalty Revenue
RoyaltyRevenue
7000000 USD
CY2017Q2 us-gaap Royalty Revenue
RoyaltyRevenue
7000000 USD
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
1162000000 USD
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
1231000000 USD
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
315000000 USD
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
309000000 USD
CY2016Q2 us-gaap Share Based Compensation
ShareBasedCompensation
9000000 USD
CY2017Q2 us-gaap Share Based Compensation
ShareBasedCompensation
11000000 USD
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0076
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.2330
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.023
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
702745 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.30
CY2017Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
55.01
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y6M
CY2016Q2 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
80000 shares
CY2017Q2 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
0 shares
CY2017Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
1400000000 USD
CY2016Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2017Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
1487000000 USD
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
1609000000 USD
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1091000000 USD
CY2016Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1187000000 USD
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1499000000 USD
CY2017Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1635000000 USD
CY2016Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
71000000 USD
CY2017Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
100000000 USD
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4410000 shares
CY2016Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
5480000 shares
CY2016Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
5475026 shares
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
9035946 shares
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
9040000 shares
CY2017Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
10562764 shares
CY2017Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
10560000 shares
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
421000000 USD
CY2017Q2 us-gaap Treasury Stock Value
TreasuryStockValue
510000000 USD
CY2016Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
76000000 USD
CY2017Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
125000000 USD
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
68000000 USD
CY2017Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
73000000 USD
CY2016Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
10000000 USD
CY2017Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
10000000 USD
CY2017Q2 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
6000000 USD
CY2016Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2100000 shares
CY2017Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2900000 shares
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
499500000 shares
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
495300000 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
497400000 shares
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
492400000 shares
CY2016Q2 zts Amortization Of Intangible Assets Not Associated With Single Function
AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction
21000000 USD
CY2017Q2 zts Amortization Of Intangible Assets Not Associated With Single Function
AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction
22000000 USD
CY2017Q2 zts Charges Due To Operating Model Changes
ChargesDueToOperatingModelChanges
2000000 USD
CY2016Q2 zts Contributed Capital Associatedwith Pension To Be Contributedby Related Party
ContributedCapitalAssociatedwithPensionToBeContributedbyRelatedParty
1000000 USD
CY2017Q2 zts Contributed Capital Associatedwith Pension To Be Contributedby Related Party
ContributedCapitalAssociatedwithPensionToBeContributedbyRelatedParty
1000000 USD
CY2016Q2 zts Cost Reduction Initiatives And Acquisition Costs
CostReductionInitiativesAndAcquisitionCosts
-25000000 USD
CY2017Q2 zts Cost Reduction Initiatives And Acquisition Costs
CostReductionInitiativesAndAcquisitionCosts
2000000 USD
CY2016Q2 zts Excess Tax Benefits
ExcessTaxBenefits
4000000 USD
CY2017Q2 zts Excess Tax Benefits
ExcessTaxBenefits
5000000 USD
CY2017Q2 zts Line Of Credit Facility Covenant Compliance Minimum Interest Coverage Ratio
LineOfCreditFacilityCovenantComplianceMinimumInterestCoverageRatio
3.50
CY2016Q2 zts Non Cash Transfersto Related Party
NonCashTransferstoRelatedParty
1000000 USD
CY2017Q2 zts Non Cash Transfersto Related Party
NonCashTransferstoRelatedParty
1000000 USD
CY2017Q2 zts Number Of Core Animal Species Marketed
NumberOfCoreAnimalSpeciesMarketed
8 species
CY2017Q2 zts Number Of International Manufacturing Sites Sold
NumberOfInternationalManufacturingSitesSold
3 site
CY2017Q2 zts Number Of Major Product Categories
NumberOfMajorProductCategories
5 category
CY2015Q2 zts Number Of Major Product Categories
NumberOfMajorProductCategories
5000 product
CY2016Q1 zts Number Of Manufacturing Sites Sold
NumberOfManufacturingSitesSold
2 site
CY2017Q2 zts Number Of Us Manufacturing Sites Sold
NumberOfUSManufacturingSitesSold
3 site
CY2017Q2 zts Numberof Manufacturing Site To Be Exited
NumberofManufacturingSiteToBeExited
10 site
CY2017Q2 zts Numberof Regional Segments
NumberofRegionalSegments
2 region
CY2016Q2 zts Operational Efficiency Consulting Charges
OperationalEfficiencyConsultingCharges
3000000 USD
CY2017Q2 zts Operational Efficiency Consulting Charges
OperationalEfficiencyConsultingCharges
0 USD
CY2016Q2 zts Restructuring And Other Related Costs Net Of Payments
RestructuringAndOtherRelatedCostsNetOfPayments
2000000 USD
CY2017Q2 zts Restructuring And Other Related Costs Net Of Payments
RestructuringAndOtherRelatedCostsNetOfPayments
-1000000 USD
CY2016Q2 zts Restructuring Charges And Acquisition Related Costs
RestructuringChargesAndAcquisitionRelatedCosts
2000000 USD
CY2017Q2 zts Restructuring Charges And Acquisition Related Costs
RestructuringChargesAndAcquisitionRelatedCosts
-1000000 USD
CY2017Q2 zts Restructuring Reserve Utilization And Other
RestructuringReserveUtilizationAndOther
22000000 USD
CY2017Q2 zts Restructuringreductionscompletiondate
Restructuringreductionscompletiondate
P3M
CY2017Q2 zts Thefairvalueofournoncontrollinginterestina Vie
ThefairvalueofournoncontrollinginterestinaVIE
13000000 USD
CY2017Q2 us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Organization</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Zoetis Inc. (including its subsidiaries, collectively, Zoetis, the company, we, us or our) is a global leader in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. We organize and operate our business in </font><font style="font-family:inherit;font-size:9pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:9pt;"> geographic regions: the United States (U.S.) and International. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We directly market our products in approximately </font><font style="font-family:inherit;font-size:9pt;">45</font><font style="font-family:inherit;font-size:9pt;"> countries across North America, Europe, Africa, Asia, Australia and South America. Our products are sold in more than </font><font style="font-family:inherit;font-size:9pt;color:#000000;text-decoration:none;">100</font><font style="font-family:inherit;font-size:9pt;"> countries, including developed markets and emerging markets. We have a diversified business, marketing products across </font><font style="font-family:inherit;font-size:9pt;color:#000000;text-decoration:none;">eight</font><font style="font-family:inherit;font-size:9pt;"> core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals); and within </font><font style="font-family:inherit;font-size:9pt;color:#000000;text-decoration:none;">five</font><font style="font-family:inherit;font-size:9pt;"> major product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.</font></div></div>
CY2017Q2 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;">Guarantees and Indemnifications </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In the ordinary course of business and in connection with the sale of assets and businesses, we indemnify our counterparties against certain liabilities that may arise in connection with the transaction or related to activities prior to the transaction. These indemnifications typically pertain to environmental, tax, employee and/or product-related matters and patent-infringement claims. If the indemnified party were to make a successful claim pursuant to the terms of the indemnification, we would be required to reimburse the loss. These indemnifications are generally subject to threshold amounts, specified claim periods and other restrictions and limitations. Historically, we have not paid significant amounts under these provisions and, as of </font><font style="font-family:inherit;font-size:9pt;color:#000000;text-decoration:none;">April&#160;2, 2017</font><font style="font-family:inherit;font-size:9pt;">, recorded amounts for the estimated fair value of these indemnifications were not significant.</font></div></div>

Files In Submission

Name View Source Status
0001555280-17-000127-index-headers.html Edgar Link pending
0001555280-17-000127-index.html Edgar Link pending
0001555280-17-000127.txt Edgar Link pending
0001555280-17-000127-xbrl.zip Edgar Link pending
a2017q110-qex12.htm Edgar Link pending
a2017q110qex15.htm Edgar Link pending
a2017q110qex311.htm Edgar Link pending
a2017q110qex312.htm Edgar Link pending
a2017q110qex321.htm Edgar Link pending
a2017q110qex322.htm Edgar Link pending
a2017q1form10-q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zts-20170402.xml Edgar Link completed
zts-20170402.xsd Edgar Link pending
zts-20170402_cal.xml Edgar Link unprocessable
zts-20170402_def.xml Edgar Link unprocessable
zts-20170402_lab.xml Edgar Link unprocessable
zts-20170402_pre.xml Edgar Link unprocessable